Replimune Group, Inc. (REPL)
2.42
-0.43
(-15.09%)
USD |
NASDAQ |
Apr 24, 16:00
2.41
-0.01
(-0.41%)
After-Hours: 20:00
Replimune Group Market Cap : 199.83M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.789B |
| Bristol Myers Squibb Co. | 119.87B |
| Phathom Pharmaceuticals, Inc. | 929.33M |
| REGENXBIO, Inc. | 452.13M |
| Catalyst Pharmaceuticals, Inc. | 3.343B |
Market Cap Related Metrics
| PEG Ratio | -0.0484 |
| Price to Book Value | 0.9491 |
| Price | 2.42 |
| Earnings Yield | -148.0% |
| PEGY Ratio | -0.0484 |